119 filings
REVOKED
NPTX
Neuropathix, Inc.
20 Oct 23
Registration or securities revoked
10:06am
NT 10-Q
NPTX
Neuropathix, Inc.
12 Aug 22
Notice of late quarterly filing
4:05pm
10-Q
2022 Q1
NPTX
Neuropathix, Inc.
Quarterly report
23 May 22
4:09pm
NT 10-Q
NPTX
Neuropathix, Inc.
16 May 22
Notice of late quarterly filing
4:08pm
10-K
2021 FY
NPTX
Neuropathix, Inc.
Annual report
15 Apr 22
12:00am
NT 10-K
028aeptvjyt8f4sh
30 Mar 22
Notice of late annual filing
8:41pm
8-K
ti53p tt8fu6r4t
24 Mar 22
Entry into a Material Definitive Agreement
8:17pm
8-K
50a7e4yr 365
28 Sep 21
Regulation FD Disclosure
9:00am
EFFECT
reulvvdt24
6 Jul 21
Notice of effectiveness
12:15am
POS AM
9vei05u2 yt6
23 Jun 21
Prospectus update (post-effective amendment)
4:50pm
8-K
efq4rh6v89
17 Mar 21
Departure of Directors or Certain Officers
4:00pm
D
iol45qqp3be1633a1lxo
23 Feb 21
$1.21M in equity / options / securities to be acquired, sold $1.21M, 1 investor
4:46pm
8-K
md9a16nyqhhfbe9wm3s
23 Feb 21
Entry into a Material Definitive Agreement
4:01pm
8-K
7k10a 3xb
21 Dec 20
Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate
4:57pm
8-K
y11vl
19 Nov 20
Neuropathix, Inc. Signs Binding Letter of Intent to Acquire Anticonvulsant – Neuroprotective Intellectual Property
9:00am